Advertisement

Topics

PeptiDream, Heptares sign deal on GPCR-targeting drug studies

06:16 EDT 30 Jun 2017 | SmartBrief

Heptares Therapeutics agreed to collaborate with PeptiDream to identify, develop and market drugs that target G protein-coupl -More

Original Article: PeptiDream, Heptares sign deal on GPCR-targeting drug studies

NEXT ARTICLE

More From BioPortfolio on "PeptiDream, Heptares sign deal on GPCR-targeting drug studies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...